ReWalk, the first company to crowdfund and subsequently trade shares on NASDAQ, announced last week it had received an initial order of 28 ReWalk Personal Exoskeleton Systems to support an ongoing national multi-center clinical trial by the Department of Veterans Affairs. The order follows an initial order of 20 systems in 2016. The Department of Veterans Affairs is the largest healthcare provider in the U.S. for people with spinal cord injury.
ReWalk, anIsrael-based company, was one of the very first companies to leverage the OurCrowd equity crowdfunding platform initially raising $1.3 million to fund their business. The company went on to IPO on the NASDAQ creating a good exit opportunity for early shareholders. Shares in ReWalk have slumped since their IPO and now trade around $2 per share.